{
    "1": {
        "question": "What percentage of post-Covid patients developed post-Covid syndrome (PCS) as stated in the study?",
        "options": {
            "A": "10%",
            "B": "12.5%",
            "C": "15%",
            "D": "20%",
            "E": "25%",
            "F": "I don't know"
        }
    },
    "2": {
        "question": "Which of the following symptoms decreased the most after SSRI treatment according to the study?",
        "options": {
            "A": "Headache",
            "B": "Chronic fatigue",
            "C": "Brainfog",
            "D": "Muscle pain",
            "E": "Dyspnoea",
            "F": "I don't know"
        }
    },
    "3": {
        "question": "What was the primary biochemical mechanism suspected to be related to PCS and improved by SSRIs?",
        "options": {
            "A": "Kynurenine pathway (KP)",
            "B": "Dopamine pathway",
            "C": "GABAergic pathway",
            "D": "Glutamine pathway",
            "E": "Histamine pathway",
            "F": "I don't know"
        }
    },
    "4": {
        "question": "Approximately what percentage of patients reported moderate to no improvement after SSRI treatment?",
        "options": {
            "A": "10%",
            "B": "25.6%",
            "C": "30%",
            "D": "36.6%",
            "E": "45%",
            "F": "I don't know"
        }
    },
    "5": {
        "question": "Which SSRI was preferentially recommended for its sigma1 receptor agonist properties in this study?",
        "options": {
            "A": "Sertraline",
            "B": "Paroxetine",
            "C": "Fluvoxamine",
            "D": "Mirtazapine",
            "E": "Amitriptyline",
            "F": "I don't know"
        }
    },
    "6": {
        "question": "What statistical method was used to assess the relationship between different outcome measures?",
        "options": {
            "A": "Pearson's correlation",
            "B": "Spearman\u2019s rank correlation",
            "C": "Linear regression",
            "D": "ANCOVA",
            "E": "T-test",
            "F": "I don't know"
        }
    },
    "7": {
        "question": "How long after beginning SSRI treatment was Part B of the questionnaire typically completed?",
        "options": {
            "A": "1-2 weeks",
            "B": "3-4 weeks",
            "C": "4-6 weeks",
            "D": "2-3 months",
            "E": "6 months",
            "F": "I don't know"
        }
    },
    "8": {
        "question": "According to the article, which neurotransmitter does the kynurenine pathway share a precursor with?",
        "options": {
            "A": "Dopamine",
            "B": "Norepinephrine",
            "C": "Histamine",
            "D": "Serotonin",
            "E": "Glutamate",
            "F": "I don't know"
        }
    },
    "9": {
        "question": "What was NOT listed as a side effect of SSRIs in patients with PCS?",
        "options": {
            "A": "Headache",
            "B": "Dizziness",
            "C": "Malaise",
            "D": "Increased appetite",
            "E": "Sleep disturbances",
            "F": "I don't know"
        }
    },
    "10": {
        "question": "Which symptom showed the least improvement with SSRI treatment?",
        "options": {
            "A": "Muscle pain",
            "B": "Brainfog",
            "C": "Palpitations",
            "D": "Sensory overload",
            "E": "PEM",
            "F": "I don't know"
        }
    },
    "11": {
        "question": "What was the main reason given for the exploratory study of SSRIs on PCS?",
        "options": {
            "A": "SSRIs were the least expensive treatment option",
            "B": "SSRIs had shown effectiveness in similar conditions",
            "C": "SSRI treatment was mandated by health authorities",
            "D": "SSRIs were believed to enhance cognitive function",
            "E": "Patients with depression required treatment",
            "F": "I don't know"
        }
    },
    "12": {
        "question": "Which population of SSRI users showed a lesser degree of improvement according to the study?",
        "options": {
            "A": "Patients without comorbidities",
            "B": "Patients with fibromyalgia",
            "C": "Patients under age 30",
            "D": "Patients with asthma",
            "E": "All patients showed similar improvement",
            "F": "I don't know"
        }
    },
    "13": {
        "question": "How were participants selected for inclusion in the study?",
        "options": {
            "A": "Random sampling from a hospital database",
            "B": "Volunteering through social media",
            "C": "Referral from general practitioners",
            "D": "Matched control group design",
            "E": "Recruitment from psychiatric clinics",
            "F": "I don't know"
        }
    },
    "14": {
        "question": "Which of the following complications was addressed by introducing low-dose titration of SSRIs?",
        "options": {
            "A": "Cost of medication",
            "B": "Patient non-compliance",
            "C": "Avoidance of serotonin syndrome",
            "D": "Memory loss",
            "E": "Increased risk of bleeding",
            "F": "I don't know"
        }
    },
    "15": {
        "question": "What was the percentage of patients working in healthcare according to the study?",
        "options": {
            "A": "10%",
            "B": "14%",
            "C": "20%",
            "D": "25%",
            "E": "31%",
            "F": "I don't know"
        }
    },
    "16": {
        "question": "Which aspect of SSRIs was NOT directly assessed in the study?",
        "options": {
            "A": "Influence on serotonin reuptake",
            "B": "Anti-inflammatory effect",
            "C": "QTc interval prolongation",
            "D": "Effect on viral replication",
            "E": "Cost-effectiveness",
            "F": "I don't know"
        }
    },
    "17": {
        "question": "What measure was used to evaluate functional ability in patients?",
        "options": {
            "A": "WHO Functional Scale",
            "B": "Bell\u2019s Functionality Score",
            "C": "Global Assessment of Functioning (GAF)",
            "D": "Fatigue Severity Scale",
            "E": "Montreal Cognitive Assessment",
            "F": "I don't know"
        }
    },
    "18": {
        "question": "What was a potential future research direction suggested in the article?",
        "options": {
            "A": "Randomized controlled trials of SSRIs in PCS",
            "B": "SSRIs for acute infection prevention",
            "C": "Comparison of SSRIs and antipsychotics",
            "D": "Study of SSRIs in post-vaccination syndrome",
            "E": "Nutritional interventions for PCS",
            "F": "I don't know"
        }
    },
    "19": {
        "question": "What significant correlation was noted between the three outcome measures in the study?",
        "options": {
            "A": "Strong negative correlation",
            "B": "No correlation",
            "C": "Weak positive correlation",
            "D": "Moderate negative correlation",
            "E": "Strong positive correlation",
            "F": "I don't know"
        }
    },
    "20": {
        "question": "What was the primary immunological effect observed with the use of SSRIs?",
        "options": {
            "A": "Increased cytokine production",
            "B": "Stabilization of histamine levels",
            "C": "Reduction of pro-inflammatory cytokines",
            "D": "Activation of plasma cells",
            "E": "Suppression of antibody formation",
            "F": "I don't know"
        }
    }
}